Genetics

This study presents the first genome-wide association study focused specifically on tumefactive demyelination, a rare and severe subtype of multiple sclerosis characterized by large tumor-like lesions in the central nervous system. By analyzing 142 TD cases and 293 controls, the authors identified a genome-wide significant variant on chromosome 14, rs117797734, with a strong association with TD risk, as well as a nominally significant signal near DCBLD1 on chromosome 6. The findings suggest that studying clinically homogeneous MS subtypes can uncover genetic variants with larger and potentially more disease-specific effects than those detected in broad MS cohorts. The study also found overlap between TD and established MS genetic risk, including several non-MHC and MHC variants, and demonstrated that polygenic risk scores for MS are elevated in TD patients. Although replication in larger and more diverse cohorts is required, this work provides an important foundation for understanding the molecular mechanisms underlying tumefactive demyelination and highlights the value of subtype-specific genetic research in complex neurological diseases.